Trial · NCT05968820
Sleep Health Enhancement in Older Adults to Address Frailty
NCT05968820, Phase 1, Completed, University of Kansas Medical Center
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Sleep Health Enhancement in Older Adults to Address Frailty. Trials, record NCT05968820. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05968820
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Sleep Health Enhancement in Older Adults to Address Frailty
- NCT number
- NCT05968820
- Status
- Completed
- Phases
- Phase 1
- Enrollment
- 40 participants, actual
- Lead sponsor
- University of Kansas Medical Center
- Conditions
- Frailty
- Interventions
- Sleep Health Enhancement Intervention
- First posted
- 2023-08-01
- Last updated
- 2024-09-19
Source ClinicalTrials.gov
Registered outcomes17
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | 6-item Acceptability Scale | 6 week | 5-point Likert scale on ease of use, understandability, enjoyment, perceived helpfulness, time commitment, and overall satisfaction |
| Primary | semi-standardized qualitative interview | 6 week | Feasibility and acceptability will be assessed via semi-structured interview with a trained graduate research assistant following standard qualitative methods to determine attitudes, perceptions and experiences of effectiveness, potential barriers, benefits, and likes/dislikes of the sleep health enhancement intervention. The interview will be recorded for analysis purposes |
| Primary | Tilburg Frailty Indicator | baseline, 6 week and 12 week reassessments | The Tilburg Frailty Indicator consists of 15 questions with score ranging from 0-15 with a higher score indicating higher level of frailty. The physical, psychological, and social frailty sub scores range from 0-8, 0-4, and 0-3 respectively. |
| Primary | WHOQOL-BREF | baseline, 6 week and 12 week reassessments | The WHOQOL-BREF consists of 26 items and 4 domains of quality of life (psychological, physical health, social relationships and environmental). Scores range from 4-20 for each domain and a higher score indicates higher quality of life. |
| Primary | Ru_SATED sleep health composite | baseline, 6 week and 12 week reassessments | Ru-SATED sleep health composite will be calculated using actigraphy data and self-report questionnaires. The domains will be summed to create the composite sleep health score ranging from 0-6 with a higher score indicating better sleep health. |
| Secondary | Pittsburgh Sleep Quality Index | baseline, 6 week and 12 week reassessments | Scores range from 0-21 with a higher score indicating a lower quality of sleep. A global score of \>5 indicates poor sleep quality. |
| Secondary | Epworth Sleepiness Scale | baseline, 6 week and 12 week reassessments | Consists of eight scenarios of daily activity, and participants use a four-point Likert scale to rate how likely they are to doze. Score ranges 0-24 with a higher score indicating daytime sleepiness. |
| Secondary | Dysfunctional Beliefs About Sleep | baseline, 6 week and 12 week reassessments | This assessment is a 10 item Likert-scale self-report questionnaire. Higher scores indicate more dysfunctional beliefs. |
| Secondary | Sleep Self-Efficacy | baseline, 6 week and 12 week reassessments | Sleep Self-Efficacy is a 9 item self-report Likert-scale questionnaire use to identify sleep self-efficacy. Scores range from 0-45 and a higher score indicates higher sleep self-efficacy. |
| Secondary | Actigraphy | baseline, 6 week and 12 week reassessments | Participants will wear an actigraph on their non-dominant wrist for 7 nights |
1 to 10 of 17Source ClinicalTrials.gov
See all 17 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests2
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Continuous Performance Test | Other outcome | ConductCognition |
| Stroop Color-Word Test | Other outcome | ConductCognition |
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05968820
GET https://conductscience.org/api/trials/v1/NCT05968820/registered